Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Common polymorphisms in CYP2C9, subclinical atherosclerosis and risk of ischemic vascular disease in 52,000 individuals.

The pharmacogenomics journal - 1 Oct 2009

Kaur-Knudsen D, Bojesen S E, Nordestgaard B G

Abstract excerpt

Cytochrome P450 2C9 (CYP2C9) enzymes metabolize warfarin and arachidonic acid. We hypothesized that the CYP2C9(*)2 (rs.1799853) and CYP2C9(*)3 (rs.1057910) polymorphisms with decreased enzyme activity affect risk of subclinical atherosclerosis (reduced ankle brachial index and increased C-reactive protein), ischemic vascular diseases (ischemic heart disease, myocardial infarction, ischemic cerebrovascular disease...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aryl Hydrocarbon Hydroxylases
Share to Atherosclerosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cardiovascular Diseases

Share to Cross-Sectional Studies

Share to Cytochrome P-450 CYP2C9

Share to Denmark

Share to Ischemia

Share to Proportional Hazards Models

Source

Identifiers

PMID: 19652664
DOI: 10.1038/tpj.2009.34

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Common polymorphisms in CYP2C9, subclinical atherosclerosis and risk of ischemic vascular disease in 52,000 individuals.PMID 19652664Read ↗

The common functional polymorphism -50G>T of the CYP2J2 gene is not associated with ischemic coronary and cerebrovascular events in an urban-based sample of Swedes.Semantic proximity Read ↗

Influence of cytochrome P450 2C9*2 and 2C9*3 variants on the risk of ischemic stroke: a cross-sectional case-control study.Semantic proximity Read ↗

Leukotriene C4 synthase and ischemic cardiovascular disease and obstructive pulmonary disease in 13,000 individuals.Semantic proximity Read ↗

A common mutation in lipoprotein lipase confers a 2-fold increase in risk of ischemic cerebrovascular disease in women but not in men.Semantic proximity Read ↗

Vitamin D and cause-specific vascular disease and mortality: a Mendelian randomisation study involving 99,012 Chinese and 106,911 European adultsSemantic proximity Read ↗

Differential effects of PCSK9 variants on risk of coronary disease and ischaemic stroke.Semantic proximity Read ↗

Polymorphisms of CYP2C8, CYP2C9 and CYP2C19 and risk of coronary heart disease in Russian population.Semantic proximity Read ↗

Hereditary hemochromatosis genotypes and risk of ischemic stroke.Semantic proximity Read ↗

Impact of CYP2C8 and 2C9 polymorphisms on coronary artery disease and myocardial infarction in the LURIC cohort.Semantic proximity Read ↗

Genetically reduced antioxidative protection and increased ischemic heart disease risk: The Copenhagen City Heart Study.Semantic proximity Read ↗

Allelic variants of cytochromes P450 2C modify the risk for acute myocardial infarction.Semantic proximity Read ↗

CYP2C9*2 and CYP2C9*3 alleles confer a lower risk for myocardial infarction.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.